Histamine Glutamate Antagonism in Stroke

Completed

Phase 2 Results

Summary of Purpose

Stroke is the 4th leading cause of death in United States with an estimated 1 death every 4 minutes. On average, someone suffers from stroke in United States every 40th second. Stroke recurs in 1 out of 4 stroke patients. About 87% of the strokes are as a result of ischemic insult. The total economic burden from stroke accounts to 38.6 billion dollars per year. Stroke is also one of the leading causes of long...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 November 2015.

1 Dec 2014 9 May 2014 1 Dec 2014 1 Dec 2014 1 Nov 2015 23 Sep 2015
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts